# A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis

> **NCT00216385** · PHASE3 · UNKNOWN · sponsor: **Institut de Recherche pour le Developpement** · enrollment: 2070 (—)

## Conditions studied

- Tuberculosis

## Interventions

- **DRUG:** Gatifloxacin combined regimen

## Key facts

- **NCT ID:** NCT00216385
- **Lead sponsor:** Institut de Recherche pour le Developpement
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 2070 (—)
- **Last updated:** 2005-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00216385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00216385, "A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary Tuberculosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00216385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*